Today’s top gainers include the company Perrigo Company plc (NYSE:PRGO) which is in the industry Drug Related Products, gaining -1.82% today. In the last week its performance is -0.69%, and -9.76% for the past quarter. Currently, Perrigo Company plc, PRGO has a target price of 102.64, so today’s gain of -1.82% is a significant step towards its target price. The GAP today is therefore 0.15%.
Perrigo Company plc (NYSE:PRGO), has a market cap of 13022.49, and is based in Ireland. Insider ownership is at 0.10%, and institutional ownership is 75.10%.
At the current price of 90.39, it has a dividend yield of 0.64%, and its target price is 102.64. This is with a profit margin of -2.40%, and total debt/equity of 0.65. Perrigo Company plc (NYSE:PRGO) has a P/E of *TBA, as well as a forward P/E of 11.63.
With a current EPS of -0.95, and a forecasted EPS growth for next year at 10.16%,Perrigo Company plc (NYSE:PRGO) has had a EPS growth for the past five years at -59.80%. For the next five years EPS growth is projected to be 7.98%.
Performance for the year is -49.71%. Since its IPO date on 12/17/1991, the total performance to date is -37.27%.
Volume today for Perrigo Company plc (NYSE:PRGO), is 1948000, while its average volume is 2485.31. Whilst the total gain today was -1.82%, it did have a day high of -6.94%.
Volatility for this week has been at 2.44%, and 2.46% for the month. The 52-week low for Perrigo Company plc, PRGO has been 9.74%, while the 52-week-high has reached -50.83%.
Looking at its return of investments, which is 0.60%, and its return on assets is -0.70%. Perrigo Company plc (NYSE:PRGO) has an operating margin of 0.50%. With a sales growth of -3.30% quarter over quarter. Bearing in mind that Perrigo Company plc, PRGO is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 1.4 and 1 for quick ratio.
So what is the value of Perrigo Company plc? Well its PEG is *TBA, and the P/S is 2.31, along with a P/B of 1.31. Meanwhile it has a p/cash of *TBA.